In others, such as esophageal squamous cell carcinoma [33], lung [34], prostate [35], melanocytic neoplasia [36] and breast cancers [28,37], claudin 1 appears to demonstrate tumor suppressor activities. This evidence concerns the gene CLDN1 and esophageal squamous cell carcinoma.